The primary purpose of this secondary data analysis was to evaluate the efficacy and suitability of the Memorial Symptom Assessment Scale (MSAS) for use with patients with severe chronic obstructive pulmonary disease (COPD). Symptoms experienced by patients with severe COPD were assessed in the original investigation using the 32-item MSAS. The sample consisted of 72 individuals with COPD ranging in age from 36 to 79 years. To increase its efficiency for use with severely ill COPD patients, the original MSAS was shortened to include the 19 most frequently reported symptoms. Reliability of the revised tool remained high (Cronbach's alpha = .86). Content and convergent validity of the revised tool were also established. The revised MSAS appears to be an appropriate measure of the multidimensional, multisymptom experience of patients with severe COPD.
American Thoracic Society Board of Directors. ( 1999). Dyspnea mechanisms, assessment, and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine, 159, 321-340.
2.
Baker, C., & Scholz, J. (2002). Coping with symptoms of dyspnea in chronic obstructive pulmonary disease. Rehabilitation Nursing, 27, 67-74.
3.
Borg, G.A. (1970). Perceived exertion as an indicator of somatic stress. Scandinavian Journal of Rehabilitation Medicine, 2, 92-98.
4.
Borg, G.A. (1982). Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise, 14, 377-381.
Cox, J.M., Dickerson, E.D., & Petty, T.L. (2003). Chronic obstructive pulmonary disease and Dyspnea: A Pandora's box of comorbid symptoms?American Journal of Hospice and Palliative Care,20, 179-181.
7.
Dodd, M.J., Miaskowski, C., & Paul, S. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465-470.
8.
Eakin, E., Resnikoff, P., Prewitt, L., Ries, A., & Kaplan, R. (1998). Validation of a new dyspnea measure. The UCSD Shortness of Breath Questionnaire. Chest, 113, 619-624.
9.
Ferrer, M., Alonso, J., Morera, J., Marrades, R., Khalaf, A., Aguar, M., et al. (1997). Chronic obstructive pulmonary disease stage and health-related quality of life. Annals of Internal Medicine , 127, 1072-1079.
10.
Field, A. (2000). Discovering statistics using SPSS for Windows . Thousand Oaks, CA: Sage.
11.
George, D., & Mallery, P. (2003). SPSS for windows step by step (4th ed.). New York: Pearson .
12.
Gift, A. (1989). Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabilitation Nursing, 14, 323-325.
13.
Graydon, J.E., & Ross, E. (1995). Influence of symptoms, lung function, mood, and social support on level of functioning of patients with COPD. Research in Nursing and Health, 18, 525-533.
14.
Guyatt, G.H., Berman, L.B., Townsend, M., Pugsley, S.O., & Chambers, L.W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax,42, 773-778.
Jones, P.W., Quirk, F.H., & Baveystock, C.M. (1991). The St. George's Respiratory Questionnaire. RespiratoryMedicine, 85(Suppl. B), 25-31.
18.
Karim, A., & Rossoff, L. (2001). Pharmacologic treatment of COPD in patients with concomitant cardiovascular disease and hypertension. Journal of COPD Management, 2(3), 4-9.
19.
Kinsman, R.A., Fernandez, E., Schocket, M., Dirks, J.F., & Covino, N.A. (1983). Multidimensional analysis of the symptoms of chronic bronchitis and emphysema. Journal of BehavioralMedicine, 6, 339-357.
20.
Kris, A.E., & Dodd, M.J. (2004). Symptom experience of adult hospitalized medical-surgical patients. Journal of Pain and Symptom Management, 28, 451-459.
21.
Lareau, S.C., Carrieri-Kohlman, V., Janson-Bjerklie, S., & Roos, P.J. (1994). Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ). Heart & Lung , 23, 242-250.
22.
Lareau, S.C., Meek, P.M., & Roos, P.J. (1998). Development and testing of the modified version of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-M). Heart & Lung, 27, 159-168.
23.
Leidy, N.K., Schmier, J.K., Jones, M.K., Lloyd, J., & Rocchioccioli, K. (2003). Evaluating symptoms in chronic obstructive pulmonary disease: Validation of the Breathlessness, Cough and Sputum Scale. Respiratory Medicine, 97(Suppl. A), S59-S70.
24.
Lenz, E.R., Pugh, L.C., Milligan, R.A., Gift, A., & Suppe, F. (1997). The middle range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14-27.
25.
Mahler, D., Weinberg, D., Wells, C., & Feinstein, A. (1984). The measurement of dyspnea: Contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest, 85, 751-758.
McDowell, I., & Newell, C. (1996). Measuring health. A guide to rating scales and questionnaires (2nd ed.). New York: Oxford University Press.
28.
Meek, P., & Lareau, S. (2003). Critical outcomes in pulmonary rehabilitation: Assessment and evaluation of dyspnea and fatigue. Journal of Rehabilitation Research & Development, 40(5), 13-24.
29.
National Heart, Lung, and Blood Institute. ( 2003). Data fact sheet: Chronic obstructive pulmonary disease . Retrieved June 25, 2006, fromhttp://www.nhlbi.nih.gov/health/public/lung/other/copd_fact.htm
30.
National Institute of Nursing Research. (2007 ). National Institute of Nursing Research draft of the strategic plan of the NINR 2006-2010. Retrieved March 5, 2007, from http://www.ninr.nih.gov/aboutNINR/NINRMissionandStrategicPlan
31.
Neter, J., Kutner, M.H., Nachtsheim, C.J., & Wasserman, W. (1996). Applied linear statistical models (4th ed.). Chicago: Times Mirror Higher Education Group.
32.
Nunnally, J.C., & Bernstein, I.H. (1994). Psychometric theory (3rd ed.). New York: McGraw-Hill.
33.
Pedhazur, E.L. (1997). Multiple regressions in behavioral research: Explanation and prediction (3rd ed.). Orlando, FL: Harcourt Brace.
34.
Portenoy, R.K., Thaler, H.T., Kornblith, A.B., Lepore, J., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A, 1326-1336.
35.
Tinsley, H.E.A., & Tinsley, D.J. (1987). Uses of factor analysis in counseling psychology research. Journal of Counseling Psychology, 34, 414-424.
36.
Tranmer, J.E., Heyland, D., Dudgeon, D., Groll.,D., Squires-Graham, D., & Coulson, K. (2003). Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. Journal of Pain and Symptom Management, 25, 420-429.
37.
U.S. Department of Health and Human Services National Institutes of Health. (2001a). Global initiative for chronic obstructive lung disease (NIH Publication No. 2701). Washington, DC: Government Printing Office.
38.
U.S. Department of Health and Human Services National Institutes of Health. (2001b). Global initiative for chronic obstructive lung disease. Pocket guide to COPD diagnosis, management, and prevention. (NIH Publication No. 2701B). Washington, DC : Government Printing Office.
39.
Ware, J.E., & Davies, A.R. (1995). Monitoring health outcomes from the patients' point of view: A primer. Kenilworth, NJ: Integrated Therapeutics Group.
40.
Yochmowitz, M.G. (1982). Factor analysis of variance model (FANOVA). In S. Kotz, N. L. Johnson, & C. B. Read (Eds.), Encyclopedia of statistical sciences (Vol. 3, pp. 9-13). New York: Wiley.
